FDA Approved: HEPARIN SODIUM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved Pfizer's supplemental application for Heparin Sodium, the anticoagulant. The approval updates the product's labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Deep Vein Thrombosis
• Myocardial Infarction
• Pulmonary Embolism
• Unstable Angina
• Venous Thromboembolism

Drugs mentioned

• HEPARIN SODIUM (HEPARIN SODIUM)

Snippet

SUPPL AP for HEPARIN SODIUM (HEPARIN SODIUM)